Scott E. Strome

15.2k total citations · 2 hit papers
144 papers, 11.5k citations indexed

About

Scott E. Strome is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Scott E. Strome has authored 144 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Immunology, 49 papers in Oncology and 40 papers in Surgery. Recurrent topics in Scott E. Strome's work include Immunotherapy and Immune Responses (45 papers), Head and Neck Cancer Studies (27 papers) and T-cell and B-cell Immunology (26 papers). Scott E. Strome is often cited by papers focused on Immunotherapy and Immune Responses (45 papers), Head and Neck Cancer Studies (27 papers) and T-cell and B-cell Immunology (26 papers). Scott E. Strome collaborates with scholars based in United States, China and Japan. Scott E. Strome's co-authors include Lieping Chen, Koji Tamada, Dallas B. Flies, Haidong Dong, Gefeng Zhu, Hideto Tamura, Diva R. Salomão, Fumiya Hirano, Patrick C. Roche and Jun Lü and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Scott E. Strome

142 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

2002 4.0k citations Haidong Dong, Scott E. Strome et al. profile →
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

2004 635 citations R. Houston Thompson, Michael D. Gillett et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott E. Strome United States	48	6.9k	6.1k	2.1k	1.5k	1.4k	144	11.5k
Sara I. Pai United States	41	2.8k 0.4×	2.1k 0.4×	2.0k 1.0×	767 0.5×	1.8k 1.3×	141	7.5k
James W. Hodge United States	61	7.8k 1.1×	7.9k 1.3×	2.7k 1.3×	2.5k 1.6×	609 0.4×	196	12.3k
Erin Murphy United States	22	6.2k 0.9×	8.4k 1.4×	3.0k 1.4×	1.5k 1.0×	2.0k 1.5×	49	13.9k
Bernward Passlick Germany	50	3.2k 0.5×	2.3k 0.4×	1.6k 0.8×	4.6k 3.0×	1.6k 1.1×	229	9.5k
Tullia C. Bruno United States	42	4.2k 0.6×	4.4k 0.7×	1.6k 0.8×	1.0k 0.7×	422 0.3×	91	7.3k
Koji Tamada Japan	54	10.6k 1.5×	11.8k 1.9×	2.8k 1.4×	1.4k 0.9×	821 0.6×	147	17.4k
Dallas B. Flies United States	38	9.4k 1.4×	10.6k 1.7×	2.3k 1.1×	1.3k 0.9×	725 0.5×	65	14.9k
Michele W.L. Teng Australia	56	9.2k 1.3×	8.3k 1.4×	3.6k 1.7×	1.9k 1.2×	833 0.6×	95	15.0k
Hilmar Lemke Germany	33	3.4k 0.5×	3.6k 0.6×	3.4k 1.6×	1.3k 0.9×	1.0k 0.7×	74	12.2k
Haidong Dong United States	60	13.7k 2.0×	11.4k 1.9×	3.4k 1.6×	3.5k 2.3×	1.6k 1.1×	182	19.8k

Countries citing papers authored by Scott E. Strome

Since Specialization

Citations

This map shows the geographic impact of Scott E. Strome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Strome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Strome more than expected).

Fields of papers citing papers by Scott E. Strome

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott E. Strome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Strome. The network helps show where Scott E. Strome may publish in the future.

Co-authorship network of co-authors of Scott E. Strome

This figure shows the co-authorship network connecting the top 25 collaborators of Scott E. Strome. A scholar is included among the top collaborators of Scott E. Strome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott E. Strome. Scott E. Strome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Strome, Scott E., et al.. (2018). Is routine genetic testing warranted in head and neck paragangliomas?. The Laryngoscope. 129(7). 1491–1493. 4 indexed citations

2.

Hatten, Kyle M., Nidhi Gupta, & Scott E. Strome. (2017). What additional treatment is indicated for oral cavity cancer with isolated perineural invasion?. The Laryngoscope. 127(9). 1965–1966. 4 indexed citations

3.

Zhang, Yue, Lukas W. Pfannenstiel, Carolina L. Montes, et al.. (2011). Interleukin-7 Inhibits Tumor-Induced CD27−CD28− Suppressor T Cells: Implications for Cancer Immunotherapy. Clinical Cancer Research. 17(15). 4975–4986. 28 indexed citations

4.

Ertl, Hildegund C.J., John A. Zaia, Steven A. Rosenberg, et al.. (2011). Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a Recombinant DNA Advisory Committee Symposium Held June 15, 2010. Cancer Research. 71(9). 3175–3181. 57 indexed citations

5.

Sakoda, Yukimi, Sudarshan Anand, Yuming Zhao, et al.. (2011). Herpesvirus entry mediator regulates hypoxia-inducible factor–1α and erythropoiesis in mice. Journal of Clinical Investigation. 121(12). 4810–4819. 10 indexed citations

6.

Park, Jang‐June, Ryusuke Omiya, Yumiko Matsumura, et al.. (2010). B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance. Blood. 116(8). 1291–1298. 266 indexed citations

7.

Posner, Marshall R., Lisa M. Schumaker, Ming Tan, et al.. (2009). Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients. Cancer Prevention Research. 2(9). 776–781. 221 indexed citations

8.

Zhang, Xiaoyu, Caroline Voskens, Michelle A. Sallin, et al.. (2009). CD137 Promotes Proliferation and Survival of Human B Cells. The Journal of Immunology. 184(2). 787–795. 54 indexed citations

9.

Han, Jing, et al.. (2009). Identification of potential therapeutic targets in human head & neck squamous cell carcinoma. Head & Neck Oncology. 1(1). 27–27. 47 indexed citations

10.

Ogle, Brenda M., Lori J. West, David J. Driscoll, et al.. (2006). Effacing of the T Cell Compartment by Cardiac Transplantation in Infancy. The Journal of Immunology. 176(3). 1962–1967. 44 indexed citations

11.

Foote, Robert L., et al.. (2006). Organ preservation for advanced laryngeal carcinoma. Head & Neck. 28(8). 689–696. 11 indexed citations

12.

Thompson, R. Houston, Michael D. Gillett, John C. Cheville, et al.. (2004). Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proceedings of the National Academy of Sciences. 101(49). 17174–17179. 635 indexed citations breakdown →

13.

Zhang, Xiaoyu & Scott E. Strome. (2004). B7-H1-targeted immunotherapy for head and neck cancer. Expert Opinion on Biological Therapy. 4(10). 1577–1583. 3 indexed citations

14.

Choi, In-Hak, Gefeng Zhu, Gabriel Sica, et al.. (2003). Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family. The Journal of Immunology. 171(9). 4650–4654. 207 indexed citations

15.

Gostout, Bobbie S., Scott E. Strome, Amy C. Clayton, et al.. (2002). Two Cases of Coincident Carcinomas of the Head and Neck and the Uterine Cervix. Gynecologic Oncology. 85(2). 376–380. 4 indexed citations

16.

Wilcox, Ryan A., Dallas B. Flies, Gefeng Zhu, et al.. (2002). Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. Journal of Clinical Investigation. 109(5). 651–659. 185 indexed citations

17.

Wilcox, Ryan A., Dallas B. Flies, Gefeng Zhu, et al.. (2002). Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. Journal of Clinical Investigation. 109(5). 651–659. 9 indexed citations

18.

Wilcox, Ryan A., Koji Tamada, Scott E. Strome, & Lieping Chen. (2002). Signaling Through NK Cell-Associated CD137 Promotes Both Helper Function for CD8+ Cytolytic T Cells and Responsiveness to IL-2 But Not Cytolytic Activity. The Journal of Immunology. 169(8). 4230–4236. 134 indexed citations

19.

Wilcox, Ryan A., Dallas B. Flies, Gefeng Zhu, et al.. (2002). Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. Journal of Clinical Investigation. 109(5). 651–659. 219 indexed citations

20.

Strome, Scott E., John C. Krauss, Alfred E. Chang, & Suyu Shu. (1993). Strategies of Lymphocyte Activation for the Adoptive Immunotherapy of Metastatic Cancer: A Review. Journal of Hematotherapy. 2(1). 63–73. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact